Skip to search formSkip to main contentSkip to account menu

Cyclosporine Ophthalmic Suspension [Restasis]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Cell penetrating peptide (CPP), LK-3, causes a ca. 10-fold increase in the cell penetration of cyclosporin A (CsA) at nanomolar… 
2017
2017
Zusammenfassung Hintergrund Alterung ist ein wichtiger, bislang in Bezug auf therapeutische Maßnahmen jedoch nur unzureichend ber… 
2014
2014
The purpose of the study was to evaluate the efficacy and acceptability of the drug Restasis® in treatment of atopic… 
2013
2013
The impact of dry eye disease on patient’s health, visual function and quality of life may be substantial. At present, the only… 
Highly Cited
2011
Highly Cited
2011
PURPOSE This retrospective, clinical comparative analysis describes differences in clinical signs and symptoms and medication… 
2008
2008
Purpose: We conducted a study to evaluate the change of tear secretion and symptoms in the patients with dry eye syndrome after…